Gene · 5733
Papers2,527
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,527
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The transcription factor Zic4 promotes tentacle formation and prevents epithelial transdifferentiation in Hydra. | Sci Adv | 2022 | 36563144 | PubTator, text mining | PubMed |
| Prostaglandin EP3 receptor-expressing preoptic neurons bidirectionally control body temperature via tonic GABAergic signaling. | Sci Adv | 2022 | 36563142 | PubTator, text mining | PubMed |
| Role of Oxylipins in the Inflammatory-Related Diseases NAFLD, Obesity, and Type 2 Diabetes. | Metabolites | 2022 | 36557276 | PubTator, text mining | PubMed |
| Plasma Prostaglandin E2 Metabolite Levels Predict Type 2 Diabetes Status and One-Year Therapeutic Response Independent of Clinical Markers of Inflammation. | Metabolites | 2022 | 36557272 | PubTator, text mining | PubMed |
| Activation of OSM-STAT3 Epigenetically Regulates Tumor-Promoting Transcriptional Programs in Cervical Cancer. | Cancers (Basel) | 2022 | 36551576 | PubTator, text mining | PubMed |
| Workplace Incivility and Employee Performance: Does Trust in Supervisors Matter? (A Dual Theory Perspective). | Behav Sci (Basel) | 2022 | 36546996 | PubTator, text mining | PubMed |
| Targeting cancer-related inflammation with non-steroidal anti-inflammatory drugs: Perspectives in pharmacogenomics. | Front Pharmacol | 2022 | 36545311 | PubTator, text mining | PubMed |
Clinical Features and Prognosis Analysis of Hormone Receptor-Positive, HER2-Negative Breast Cancer with Differential Expression Levels of Estrogen and Progesterone Receptors: A 10-Year Retrospective Study. | Breast J | 2022 | 36531979 | PubTator, text mining | PubMed |
| Inhibition of Prostaglandin E2 Receptor EP3 Attenuates Oxidative Stress and Neuronal Apoptosis Partially by Modulating p38MAPK/FOXO3/Mul1/Mfn2 Pathway after Subarachnoid Hemorrhage in Rats. | Oxid Med Cell Longev | 2022 | 36531208 | PubTator, text mining | PubMed |
| Bioinformatics identification and validation of biomarkers and infiltrating immune cells in endometriosis. | Front Immunol | 2022 | 36524127 | PubTator, text mining | PubMed |
| Community extension MSME's entrepreneurial activities in relation to poverty reduction. | Front Sociol | 2022 | 36518151 | PubTator, text mining | PubMed |
| The Study of the Extracellular Matrix in Chronic Inflammation: A Way to Prevent Cancer Initiation? | Cancers (Basel) | 2022 | 36497384 | PubTator, text mining | PubMed |
| A Segmental Approach from Molecular Profiling to Medical Imaging to Study Bicuspid Aortic Valve Aortopathy. | Cells | 2022 | 36496981 | PubTator, text mining | PubMed |
| A Novel Inflammatory Response-Related Gene Signature Predicts Immune Status and Prognosis of Breast Cancer. | J Oncol | 2022 | 36467500 | PubTator, text mining | PubMed |
| Mechanisms and biomarkers of successful allergen-specific immunotherapy. | Asia Pac Allergy | 2022 | 36452016 | PubTator, text mining | PubMed |
| Blocking of The Prostaglandin E2 Receptor as a Therapeutic Strategy for Treatment of Breast Cancer: Promising Findings in a Mouse Model. | Asian Pac J Cancer Prev | 2022 | 36444589 | PubTator, text mining | PubMed |
| Evaluation of Preprocessing Methods on Independent Medical Hyperspectral Databases to Improve Analysis. | Sensors (Basel) | 2022 | 36433516 | PubTator, text mining | PubMed |
Cytotoxicity, Mitochondrial Functionality, and Redox Status of Human Conjunctival Cells after Short and Chronic Exposure to Preservative-Free Bimatoprost 0.03% and 0.01%: An In Vitro Comparative Study. | Int J Mol Sci | 2022 | 36430590 | PubTator, text mining | PubMed |
| Signaling Pathways Regulating Human Cervical Ripening in Preterm and Term Delivery. | Cells | 2022 | 36429118 | PubTator, text mining | PubMed |
| Whole-exome sequencing identifies novel protein-altering variants associated with serum apolipoprotein and lipid concentrations. | Genome Med | 2022 | 36419110 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5733/papers?page=15